Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Will my PlexusDx price increase if my doctor raises my semaglutide dose beyond 40 units
This benefit is particularly relevant if youre regularly exposed to pollution, alcohol, stress, and poor sleep, all of which can increase oxidative stress and place additional demands on the liver
launch pending approval Zepbound Kwikpen regulatory action Lilly Q1 2026 earnings (early May) Novo Q1 2026 earnings (early May, watch for any GLP-1 psychiatric trial announcements) Q3 and Q4 2026 Retatrutide TRIUMPH-1, TRIUMPH-2, TRIUMPH-3 topline readouts (obesity, OSA) Retatrutide TRANSCEND-T2D readouts (diabetes) Orforglipron ACHIEVE-4 Phase 3 T2D readout Brenipatide for MDD Phase 3 trial initiation Eloralintide Phase 3 initiation 2027 Expected earliest topline results for brenipatide Phase 3 in alcohol use disorder Expected earliest topline results for brenipatide Phase 3 in bipolar disorder Possible regulatory submissions for retatrutide in lead obesity indications Lilly R&D Day announcements expanding the brenipatide program to additional indications (likely) 2028 Earliest realistic FDA decision on brenipatide for AUD assuming successful Phase 3 Phase 2 readouts for brenipatide in smoking, opioid use disorder, and asthma None of these dates are guaranteed
Current Successes and Breakthroughs with Semaglutide Preliminary studies indicate that it may have potential benefits for individuals struggling with types 2 diabetes and other metabolic disorders
US$ 20.62
US$ 29.82
US$ 28.40
